Occupational Respiratory Wellness Programme
Measure. Support. Reassess.
Advancing Respiratory Health Through Data
LungSync™ brings baseline spirometry, airway-clearance support with AirPhysio®, and reassessment into one record — so you can see participation, adherence and outcome trends across your workforce.
This platform records measurements taken by your health practitioner and readings you self-report. It does not diagnose or treat any condition.
The programme
A three-step clinical protocol your OH team already understands
Measure
An occupational health nurse or practitioner runs baseline spirometry on your workers — FEV1, FVC, PEF — alongside a short symptom check. Values and trends only; no diagnosis by the platform.
Support
Where results or symptoms meet your site criteria, a worker is issued an AirPhysio® airway-clearance device and supported with daily use, reminders and technique guidance.
Reassess
At 4–8 weeks, spirometry is repeated. LungSync produces a before/after report — de-identified aggregates for the employer, an identified clinical copy for the practitioner.
The report
One click turns the programme into a before/after report
At reassessment, LungSync generates a branded PDF: aggregate outcomes for the employer, an identified clinical appendix for the practitioner. Here is the format — the figures below are illustrative, not a measured result.
Cohort at a glance
of eligible workers enrolled
logged daily device use
of the cohort at reassessment
Cohort mean trend (illustrative)
Values are self-reported / practitioner-recorded readings — no diagnosis.
Illustrative preview only. Employer views are de-identified aggregates and never render for a group smaller than 10. Your pilot report reflects your cohort's actual data.
Evidence summary
Honest evidence, cited at source
We describe the mechanism and the published research plainly, and every workplace pilot measures its own cohort's before-and-after result rather than promising a fixed gain.
OPEP
Oscillating positive expiratory pressure — the mechanism AirPhysio uses to support airway clearance and lung expansion.
4–8 wks
Typical reassessment window between baseline and follow-up spirometry in a workplace programme.
≥ 10
Minimum cohort size before any employer aggregate is shown — de-identification is enforced, not optional.
Read the published studies, each summarised with its citation and evidence level, in the LungSync evidence library. Claims are limited to airway clearance and lung-expansion support; the platform makes no diagnostic or measurement claims.
Open the evidence libraryThe device
AirPhysio® — drug-free airway clearance
A handheld OPEP — Oscillating Positive Expiratory Pressure device that helps loosen mucus and support lung expansion. Four variants matched to lung capacity. LungSync tracks daily use and reassessment; the device is purchased from the official South African store.
R845 incl. 15% VAT · per device · drug-free & reusable
Average Lung Capacity
Most adults — general airway clearance & lung fitness
R845incl. 15% VAT
Buy on airphysio.co.zaHow OPEP compares
Airway-clearance support options at a glance.
| AirPhysio® (OPEP) | Manual techniques | Nebulisers / inhalers | |
|---|---|---|---|
| Drug-free | Yes | Yes | — |
| Handheld & portable | Yes | — | Varies |
| Self-administered at work | Yes | Training needed | Varies |
| Reusable | Yes | Yes | — |
| Supports mucus clearance & lung expansion | Yes | Yes | Different purpose |
AirPhysio® is a trademark of its manufacturer. Support claims are limited to airway clearance and lung-expansion support. Always follow the manufacturer's instructions and your health practitioner's guidance. Not suitable for everyone — see contraindications.
Employer ROI
What respiratory absence is costing you — and the saving band
Adjust the assumptions for your workforce. This is a planning estimate to frame a pilot business case, not a clinical or financial guarantee.
Adjust the assumptions to match your workforce. The saving band models a 10–25% reduction in respiratory-related absence — a planning estimate, not a guaranteed or measured clinical outcome.
Estimated annual cost of respiratory-related absence
R 750 000
R 75 000 – R 187 500
Based on your inputs across a 12-month programme.
Book a 60-day workplace pilot
We'll design a Measure–Support–Reassess pilot for one of your sites: baseline spirometry, device issue, daily support, and a reassessment report at 4–8 weeks — with a de-identified outcomes summary for your leadership.
- • Aggregate reporting only for employers (minimum cohort of 10)
- • Consent-first and POPIA-aligned from day one
- • Runs alongside your existing occupational health provider